Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA.

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...

While charitable dollars have flowed in to plug some gaps, “philanthropy cannot replace federal funding,” said Dustin Sposato ...

Democrats in the U.S. Senate slammed Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. for cutting biomedical research and public health programs at the committee hearing.

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.

While the Trump administration targets COVID-19-related research, a new report from the ECDC shows the benefits of ...

In a recent study, a research team from the Medical University of Vienna has gained new insights into post-COVID syndrome ...

In a recent study, a research team from the Medical University of Vienna has gained new insights into post-COVID syndrome ...

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

Earlier this month, the US government announced a US$500 million (£377 million) investment to accelerate research into ...

New data suggests India's true COVID-19 death toll may be seven times higher than official figures, raising questions about ...

Rather, it is the complex interactions between pupil absence and exclusions, the ongoing impacts on children with special ...